ConductScience.org, home

Comparison · NCT03481777-sae

Remote Ischemic Conditioning (RIC) vs Sham: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Remote Ischemic Conditioning (RIC) vs Sham: serious adverse events. Trial comparisons, record NCT03481777-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03481777-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.470.4330.507wilson
Risk in group 20.4510.4150.488wilson
Risk difference, group 1 minus group 20.0185-0.03310.0699newcombe hybrid score
Risk ratio, group 1 over group 21.040.9311.16log
Odds ratio, group 1 over group 21.080.8751.33log
Number needed to harm, for one more participant with a serious adverse event on Remote Ischemic Conditioning (RIC) than on Sham54.2from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: sham.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Remote Ischemic Conditioning (RIC)Patients with acute ischemic stroke or intracerbreral hemorrhage treated with Remote Ischemic Conditioning335713EG000
Group 2ShamPatients with acute ischemic stroke or intracerbreral hemorrhage treated with Sham325720EG001

Harm

What it counts
Total, serious adverse events
Time frame
90 days

Source ClinicalTrials.gov

Trial

Title
Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST)
NCT number
NCT03481777
Phases
NA
Conditions
Stroke, Acute, Ischemic Stroke, Hemorrhagic Stroke, Intracerebral Hemorrhage, Cerebrovascular Disorders, Central Nervous System Diseases
Interventions
Remote Ischemic Conditioning, Sham Remote Ischemic Conditioning
Lead sponsor
Grethe Andersen
Results first posted
2025-01-27

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03481777-sae